Patent protection secures exclusivity until at least 2030
T2DM is characterized by the presence of chronic fluctuating hyperglycemia, obesity-associated insulin resistance as well as the impaired secretion of insulin and dysfunction of the incretin system
GLP1 receptor agonists are a class of drugs used to treat Type 2 diabetes mellitus (T2DM) and obesity
Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals
Mounjaro, a dual agonist, targets GLP-1 and GIP receptors, often resulting in more significant weight loss
The highest incidence of this type of cancer traditionally has been seen in Asia, where the incidence is as high as 72.5% of the global incidence and the mortality rate is 73.3%